Historical salary details - Mr. Charles F. Wagner, Jr, Executive Vice President and Chief Financial Officer, Vertex Pharmaceuticals, Inc.
Mr. Charles F. Wagner, Jr has been the Executive Vice President and Chief Financial Officer of Vertex Pharmaceuticals, Inc. since 12 Feb 2019. View his historical salary.
Mr. Charles F. Wagner, Jr
Executive Vice President and Chief Financial Officer
-
Gross Remuneration
-
Current Company
Vertex Pharmaceuticals, Inc.
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2025 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Financial Officer | - | - |
| 2024 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Financial Officer | - | - |
| 2023 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Financial Officer | 7.4 M | 26.8 % |
| 2022 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Financial Officer | 5.8 M | -6.6 % |
| 2021 | Vertex Pharmaceuticals, Inc. | - | 6.2 M | 2.2 % |
| 2021 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Financial Officer | 6.2 M | 2.2 % |
| 2020 | Vertex Pharmaceuticals, Inc. | - | 6.1 M | 74.6 % |
| 2020 | Vertex Pharmaceuticals, Inc. | - | 6.1 M | 74.6 % |
| 2020 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Financial Officer | 6.1 M | 74.6 % |
| 2019 | Vertex Pharmaceuticals, Inc. | - | 3.5 M | - |
| 2019 | Vertex Pharmaceuticals, Inc. | - | 3.5 M | - |
| 2019 | Vertex Pharmaceuticals, Inc. | Executive Vice President and Chief Financial Officer | 3.5 M | - |